Gasified solutions with improved organoleptic properties

By adding bubble modifiers, such as caffeic acid and quinilic acid, the problem of regulating bubble size and stability in gasified beverages is solved, and the effect of reducing bubble size and increasing foam volume is achieved, which is improved. The sensory properties of the beverage.

CN113784626BActive Publication Date: 2024-11-22CARGILL INC
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
CN202080033451.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-04-10
Filing Date
2020-04-06
Publication Date
2024-11-22
Estimated Expiration
2040-04-06

AI Technical Summary

Technical Problem

The bubble size and stability in existing gasified beverages are difficult to effectively regulate, affecting the sensory characteristics of the beverages, such as visual attractiveness and taste, and the prior art is difficult to simultaneously reduce bubble size and improve foam volume and stability.

Method used

The steviol glycoside solution containing bubble modifier is used to reduce the bubble size and improve the foam volume and stability by adding compounds such as caffeic acid, ferulic acid, quinilic acid, etc. to improve the sensory characteristics of the beverage.

Benefits of technology

Effectively reduce bubble size, improve foam volume and stability, enhance the visual appeal and taste of beverages, and meet consumers' demand for small bubbles and high foam volumes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113784626B_ABST
    Figure CN113784626B_ABST
Patent Text Reader

Abstract

The present disclosure describes a bubble modifier that can reduce the average bubble diameter of a gasified aqueous solution such as a carbonated beverage. The bubble modifier may include one or more compounds selected from the following: monocaffeoylquinic acid, dicaffeoylquinic acid, monoferuloylquinic acid, diferuloylquinic acid, monocoumaroylquinic acid, dicoumaroylquinic acid, and salts thereof. The bubble modifier advantageously includes less than 0.3% by weight of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or less than 0.05% by weight of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, or acetic acid; or less than about 0.05% by weight of chlorophyll; or less than about 0.1% by weight of furan, furan-containing chemicals, theobromine, theophylline, or trigonelline.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of the following patent applications: U.S. Application No. 62 / 830,443, filed April 6, 2019, entitled “Gasified Solutions With Improved Sensory Properties”; U.S. Application No. 62 / 832,250, filed April 10, 2019, entitled “Gasified Solutions With Improved Sensory Properties”; U.S. Application No. 16 / 374,388, filed April 3, 2019, entitled “Steviol Glycoside Compositions With Reduced Surface Tension”, published as U.S. Patent Application No. 2019 / 0223482 on July 25, 2019; International Application No. PCT / US2018 / 054804, filed October 8, 2018, entitled “Steviol Glycoside Compositions With Reduced Surface Tension”; International Application No. PCT / US2018 / 054804, filed October 5, 2018, entitled “Steviol Glycoside Solubility No. 62 / 676,722, filed on May 25, 2018, and entitled “Methods for Making Yerba Mate Extract Composition.” The entire text of each of these patent applications is hereby incorporated by reference. Technical Field

[0003] The present disclosure relates generally to gasified solutions, such as carbonated or nitrogenated beverages, and more particularly, to providing gasified solutions having enhanced bubble characteristics. Background Art

[0004] Gasified beverages are sold in huge quantities around the world. The bubbles in such beverages can enhance the appearance, flavor release and mouthfeel of the beverage. Non-alcoholic carbonated beverages obtain their bubbles through carbonation (i.e., dissolved CO2). The characteristics that affect the number of bubbles that may be formed in a single cup include the interaction between dissolved CO2, the tiny air traps that serve as bubble nucleation sites trapped in the particles, and the rising bubble dynamics. Alcoholic beverages can obtain bubbles through carbonation (e.g., sparkling wine) or through nitrogenation (i.e., dissolved nitrogen (e.g., beer)). Some coffee beverages and energy drinks are nitrogenous, to facilitate mouthfeel and flavor release.

[0005] Bubbles typically appear in carbonated beverages when CO2 concentration levels are 3-5 times higher than the saturation equilibrium value and depend on the pre-existing gas-liquid interface (Lubetkin and Blackwell, 1988; Wilt, 1986). The growth rate and rise speed of the bubbles are affected by the concentration of available carbon dioxide in the liquid phase and by the presence of stretch-active molecules (proteins, sugars) in the solution and on the bubble wall, causing them to grow slower or faster (Jones, Evans, and Galvin, 1999; Odake, 2001).

[0006] The initial bubble size distribution in beverage foam depends on the process of bubble formation, i.e. the number of bubbles per unit time, the shape and wetting properties of the cavity, the supersaturation of the liquid with gas, the rheological surface properties of the liquid, and the flow speed and direction of the liquid around the bubbles.

[0007] The gas phase in a beverage can have a considerable impact on sensory properties, including visual appeal, mouthfeel, and flavor release. In summary, the beneficial effects of bubbles on a sensory level are threefold: 1) visual appeal from the frequency of bubble formation (Liger-Belair, 2006), 2) the growth rate of bubbles rising in the cup (Liger-Belair et al., 2012), and 3) tingling in the mouth. The foam head on the beverage can also make it more attractive. In addition, the size distribution and number of bubbles formed per unit time affect the appearance and stability of the foam. A wide bubble size distribution can promote the feeling of "needle-like" bubbles or coarse foam. Smaller bubbles contribute to a stronger effervescent or creamier feel of the foam. Research by Barker et al. (2002) showed that consumers prefer smaller bubbles; in a sensory study, 87% of panelists were able to correctly identify more highly carbonated samples, and 73% of panelists perceived samples containing smaller bubbles as more highly carbonated. In other related tests, samples containing smaller bubbles consistently outperformed samples with larger "normal" sized bubbles. Summary of the invention

[0008] The present disclosure generally relates to gasified aqueous solutions, such as gasified beverages, having bubble modifiers that enhance bubble characteristics by reducing bubble size in the liquid phase, reducing bubble size in foam on the solution, and / or stabilizing foam on the solution. BRIEF DESCRIPTION OF THE DRAWINGS

[0009] Figure 1 Digital photographs showing bubbles in an aqueous solution of steviol glycosides during and after bubbling with air for 40 seconds.

[0010] Figure 2A A digital photograph showing bubbles in an aqueous solution of steviol glycosides with a bubble modifier after bubbling with air for 40 seconds.

[0011] Figure 2B A digital photograph showing bubbles in an aqueous solution of steviol glycosides with a bubble modifier after bubbling with air for 60 seconds.

[0012] Figure 2C A digital photograph showing bubbles in an aqueous solution of steviol glycosides with a bubble modifier after bubbling with air to reach a final volume of 250 ml.

[0013] Figure 3A A digital photograph showing bubbles in a lemon-lime flavored steviol glycoside solution with a bubble modifier after bubbling with air for 40 seconds.

[0014] Figure 3B A digital photograph showing bubbles in a lemon-lime flavored steviol glycoside solution with a bubble modifier after bubbling with air for 60 seconds.

[0015] Figure 3C A digital photograph showing bubbles in a lemon-lime flavored steviol glycoside solution with a bubble modifier after sparging with air to reach a final volume of 250 ml.

[0016] Figure 4A A digital photograph showing bubbles of a cola-flavored steviol glycoside solution with a bubble modifier after bubbling with air for 40 seconds.

[0017] Figure 4B A digital photograph showing bubbles of a cola-flavored steviol glycoside solution with a bubble modifier after bubbling with air for 40 seconds.

[0018] Figure 4C A digital photograph showing bubbles in a cola-flavored steviol glycoside solution with a bubble modifier after bubbling with air to reach a final volume of 250 ml.

[0019] Figure 5A Digital photographs of bubbles in steviol glycoside solutions during and after bubbling with air or nitrogen for 40 seconds are shown.

[0020] Figure 5B Digital photographs of bubbles of steviol glycoside solutions with bubble modifiers during and after bubbling with air or nitrogen for 40 seconds are shown.

[0021] Figure 5C Digital photographs of bubbles of steviol glycoside solutions with bubble modifiers and preservatives during and after bubbling with air or nitrogen for 40 seconds are shown.

[0022] Fig. 6A Digital photographs of bubbles of orange-flavored steviol glycoside solutions during and after bubbling with air or nitrogen for 40 seconds are shown.

[0023] Figure 6B Digital photographs of bubbles of an orange-flavored steviol glycoside solution with a bubble modifier are shown during and after bubbling with air or nitrogen for 40 seconds.

[0024] Fig. 7A It is a graph showing the change in average foam bubble size over time for an aqueous solution bubbled with air.

[0025] Figure 7B is a graph showing the change in average foam bubble size over time for aqueous solutions bubbled with nitrogen.

[0026] Figure 7C is a graph showing the change in average foam bubble size over time for aqueous solutions bubbled with air and nitrogen.

[0027] Fig.7D is a graph showing the average foam bubble size over time for orange flavored aqueous solutions bubbled with air and nitrogen.

[0028] Figure 8 are photographs of sugar-free carbonated water samples with different concentrations of bubble modifiers. DETAILED DESCRIPTION

[0029] The present disclosure is generally directed to bubble modifiers that 1) can reduce bubble size in gasified aqueous solutions (e.g., carbonated or nitrogen-containing beverages) and 2) can increase foam volume and foam stability when used with steviol glycoside compounds in modified steviol glycoside solutions. This can improve the sensory properties of beverages incorporating features according to the present disclosure, such as visual appeal and mouthfeel.

[0030] As used herein, a vaporized aqueous solution is an aqueous solution containing a content of dissolved gas that will cause the solution to effervescence when left at rest (i.e., not actively stirred or agitated) in a smooth-walled glass container. Whether a given solution effervescences may depend on many factors, such as the pressure to which the solution is subjected and its temperature. For purposes of this disclosure, an aqueous solution may be considered a vaporized aqueous solution if it effervescences at an ambient air pressure of 15.6°C; a temperature of 15.6°C and an ambient air pressure of 1 atmosphere are referred to herein as "STP".

[0031] As used herein, a modified steviol glycoside solution is an aqueous solution containing both steviol glycoside and a bubble modifier.

[0032] As used herein, the term "steviol glycosides" refers to the total content of steviol glycoside compounds. The weight of steviol glycosides and their components is measured by dry weight (anhydrous weight). Unless otherwise specified herein, the "amount" of steviol glycosides refers to the weight percentage (wt%) of the total content of steviol glycoside compounds.

[0033] Unless expressly indicated otherwise, ppm is based on weight. Unless the context indicates otherwise, percentages not otherwise defined herein are percentages by weight.

[0034] As described in detail below, solutions according to the present disclosure include a gas bubble modifier and may also include steviol glycosides.

[0035] Bubble modifier

[0036] The bubble modifiers disclosed herein can reduce the size of bubbles in the gasified aqueous solution and / or change the foaming characteristics of the modified steviol glycoside solution, for example, by changing the foam capacity (as discussed below), the volume stability of the foam, the amount of foam produced, the foam expansion (as discussed below) and / or the foam density. The bubble modifier can include a single bubble modifying compound or more than one bubble modifying compound.

[0037] Examples of suitable gas bubble modifier compounds for use in the gasified aqueous solutions and modified steviol glycoside solutions of the present disclosure include:

[0038] caffeic acid; esters of caffeic acid; esters of caffeic acid and quinic acid; monocaffeoylquinic acid, i.e., esters of caffeic acid and quinic acid comprising a single caffeic acid moiety, such as chlorogenic acid, cryptochlorogenic acid, or neochlorogenic acid (the structures of each are provided herein); esters of caffeic acid and quinic acid comprising more than one caffeic acid moiety, such as dicaffeoylquinic acid, i.e., esters of caffeic acid and quinic acid comprising two caffeic acid moieties, for example, 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, or 4,5-dicaffeoylquinic acid (the structures of each are provided herein);

[0039] ferulic acid; esters of ferulic acid; esters of ferulic acid and quinic acid; monoferuloylquinic acid, i.e. esters of ferulic acid and quinic acid comprising a single ferulic acid moiety, for example 3-O-feruloylquinic acid, 4-O-feruloylquinic acid, 5-O-feruloylquinic acid; esters of ferulic acid and quinic acid comprising more than one ferulic acid moiety, such as diferuloylquinic acid, i.e. esters of ferulic acid and quinic acid comprising two ferulic acid moieties, for example 3,4-diferuloylquinic acid, 3,5-diferuloylquinic acid and 4,5-diferuloylquinic acid;

[0040] Quinic acid and quinic acid esters;

[0041] Tartaric acid, tartaric acid derivatives, tartaric acid esters, tartaric acid derivative esters;

[0042] 3-(3,4-dihydroxyphenyl)lactic acid, 3-(3,4-dihydroxyphenyl)lactic acid derivatives, esters of 3-(3,4-dihydroxyphenyl)lactic acid, esters of 3-(3,4-dihydroxyphenyl)lactic acid derivatives;

[0043] p-Coumaric acid, esters of p-coumaric acid, esters of p-coumaric acid and quinic acid, esters of p-coumaric acid and quinic acid containing a single p-coumaric acid moiety, esters of p-coumaric acid and quinic acid containing more than one p-coumaric acid moiety; and

[0044] - Sinapic acid, esters of sinapic acid, esters of sinapic acid and quinic acid, esters of sinapic acid and quinic acid containing a single sinapic acid moiety, esters of sinapic acid and quinic acid containing more than one sinapic acid moiety.

[0045] These bubble modifier compounds may be in their acid form or in salt form, for example as quaternary ammonium, sodium, potassium, lithium, magnesium or calcium salts, or combinations of such salts.

[0046] In some aspects, the bubble modifier comprises at least one, at least 2, at least 3 or more compounds selected from the group consisting of 3-O-coumaroylquinic acid, 4-O-coumaroylquinic acid, 5-O-coumaroylquinic acid, 3,4-dicoumaroylquinic acid, 3,5-dicoumaroylquinic acid and 4,5-dicoumaroylquinic acid.

[0047] Caffeic acid has the following structure:

[0048]

[0049] Ferulic acid has the following structure:

[0050]

[0051] p-Coumaric acid has the following structure:

[0052]

[0053] Sinapic acid has the following structure:

[0054]

[0055] Quinic acid has the following structure:

[0056]

[0057] 3-(3,4-Dihydroxyphenyl)lactic acid has the following structure:

[0058]

[0059] Tartaric acid has the following structure:

[0060]

[0061] And available in D and L forms.

[0062] Examples of esters of various acids contemplated herein include esters of caffeic acid and tartaric acid, including chicoric acid having the following structure:

[0063]

[0064] It has two caffeic acid molecules attached to a tartaric acid core; and caffeoyltartaric acid having the following structure:

[0065]

[0066] It has one caffeic acid molecule attached to a tartaric acid core.

[0067] Examples of esters of various acids contemplated herein also include esters of caffeic acid and 3-(3,4-dihydroxyphenyl)lactic acid, including, for example, rosmarinic acid, which has the following structure:

[0068]

[0069] Examples of esters of various acids contemplated herein include esters of caffeic acid and quinic acid, including monocaffeoylquinic acids (e.g., chlorogenic acid, neochlorogenic acid, and cryptochlorogenic acid) and dicaffeoylquinic acids (e.g., 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid), and salts thereof:

[0070]

[0071] Chlorogenic acid

[0072]

[0073] Neochlorogenic Acid

[0074]

[0075] Cryptochlorogenic acid

[0076]

[0077] 1,5-dicaffeoylquinic acid

[0078]

[0079] 1,4-dicaffeoylquinic acid

[0080]

[0081] 1,3-dicaffeoylquinic acid

[0082]

[0083] 4,5-dicaffeoylquinic acid

[0084]

[0085] 3,5-dicaffeoylquinic acid

[0086]

[0087] 3,4-dicaffeoylquinic acid

[0088] Of these, 4,5-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 3,4-dicaffeoylquinic acid are the most common in the compositions contemplated herein and are found in large quantities in stevia, yerba mate, artichoke, and green coffee.

[0089] Caffeic acid, monocaffeoylquinic acid, dicaffeoylquinic acid, and other bubble modifier compounds can be considered to be weak acids, and they can each exist in at least one of their conjugate acid form, conjugate base form (e.g., in the form of their salts), and mixed conjugate acid-conjugate base form, wherein a portion (e.g., molar fraction) of the compound exists in the conjugate acid form and another portion exists in the conjugate base form. The fraction of the conjugate acid form to the conjugate base form of caffeic acid, monocaffeoylquinic acid, dicaffeoylquinic acid, and other bubble modifier compounds will depend on various factors, including the pKa of each compound and the pH of the composition.

[0090] Examples of salts of caffeic acid, monocaffeoylquinic acid, dicaffeoylquinic acid, and other bubble modifier compounds include, but are not limited to, their quaternary ammonium, sodium, potassium, lithium, magnesium, and calcium salts, or combinations of such salts.

[0091] In some aspects, the bubble modifier may be enriched with one or more of caffeic acid, monocaffeoylquinic acid, and dicaffeoylquinic acid. The term "enriched" means that the amount of one of caffeic acid, monocaffeoylquinic acid, and dicaffeoylquinic acid is increased relative to one or more other compounds present in the bubble modifier. Bubble modifiers enriched with one or more of caffeic acid, monocaffeoylquinic acid, and dicaffeoylquinic acid can enhance bubble modification, for example, further reduce bubble size in gaseous aqueous solution and / or change the foam properties of the modified steviol glycoside solution.

[0092] In some aspects, the bubble modifier enriched with one or more dicaffeoylquinic acids may contain 10% or more, 15% or more, 20% or more, 25% or more, 30% or more, 35% or more, 40% or more, 45% or more, 50% or more, 60% or more, 70% or more, 80% or more, or 90% or more dicaffeoylquinic acid. In other aspects, the bubble modifier enriched in dicaffeoylquinic acid may comprise 10% or more, 15% or more, 20% or more, 25% or more, 30% or more, 35% or more, 40% or more, 45% or more, or 50% or more, 60% or more, 70% or more, or 80% or more, or 90% or more of a combination of one or more of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid and 4,5-dicaffeoylquinic acid and salts thereof.

[0093] Certain preferred bubble modifiers specifically include a dicaffeoylquinic acid (DCQ) component and a monocaffeoylquinic acid (MCQ) component. The DCQ component includes at least one (advantageously at least 2 or at least 3) dicaffeoylquinic acid or a salt thereof. In one aspect, the DCQ component includes at least one compound selected from the following: 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and their salts. The MCQ component includes at least one (advantageously at least 2 or at least 3) monocaffeoylquinic acid or a salt thereof. In one aspect, the MCQ component includes at least one compound selected from the following: chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid and their salts.

[0094] The DCQ component and the MCQ component together may comprise greater than 50 weight percent ("(wt) %" or "wt %) of the gas bubble modifier. Advantageously, the DCQ component and the MCQ component together comprise more than 60 wt %, more than 70 wt %, more than 80 wt %, more than 90 wt %, more than 95 wt %, or more than 98 wt % of the gas bubble modifier.

[0095] In addition to the MCQ and DCQ components, the bubble modifier may also include a bubble modifier compound. A useful bubble modifier includes an MCQ component, a DCQ component, and one or more compounds selected from the following: caffeic acid, ferulic acid, p-coumaric acid, sinapinic acid, quinic acid, 3-(3,4-dihydroxyphenyl) lactic acid, tartaric acid, chicoric acid, caffeoyltartaric acid, monoferuloylquinic acid, diferuloylquinic acid, monocoumaroylquinic acid, dicoumaroylquinic acid, and their salts. In certain aspects, such bubble modifiers include an MCQ component, a DCQ component, and one or more compounds selected from the following: caffeic acid, monoferuloylquinic acid, diferuloylquinic acid, and their salts. In a specific implementation, the MCQ component, the DCQ component, and one or more compounds selected from the group together account for more than 70 (weight)%, more than 75 (weight)%, more than 80 (weight)%, more than 90 (weight)%, more than 95 (weight)%, or more than 98 (weight)% of the bubble modifier.

[0096] The weight ratio of the DCQ component to the MCQ component may be at least 0.2, at least 0.33, or at least 0.5. Preferably, the ratio is at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, or at least 10. In certain aspects, the ratio is no more than 20 or no more than 10, such as between 1 and 20, preferably between 1 and 10, between 2 and 10, between 3 and 10, between 4 and 10, or between 5 and 10. Depending on the plant source, the increasing ratio of the DCQ component to the MCQ component can increase the processing cost of obtaining the bubble modifier without adversely affecting the relevant commercial use, such as the use in beverages with less than 1,000 ppm of steviol glycosides.

[0097] Certain commercially available bubble modifiers have a weight ratio of the DCQ component to the MCQ component between 0.33 and 5. Such compositions have been found to produce non-alcoholic beverages with particularly desirable organoleptic properties. Thus, in some aspects, the weight ratio of the DCQ component to the MCQ component in the bubble modifier is between 0.33 and 5, between 0.5 and 5, between 1 and 5, between 1.5 and 5, between 2 and 5, between 3 and 5, between 0.5 and 4, between 1 and 4, between 1.5 and 4, between 0.5 and 3, between 1 and 3, or between 1.5 and 3.

[0098] A suitable bubble modifier has a weight ratio of DCQ component to MCQ component of at least 1, preferably at least 2, at least 3 or at least 4, and the DCQ component and MCQ component together account for more than 70 (weight)% of the bubble modifier, for example, more than 80 (weight)% or more than 90 (weight)%.

[0099] The bubble modifier or the bubble modifier compound used in the bubble modifier can be separated in a variety of ways. Some suitable methods are disclosed in more detail in U.S. Provisional Application Serial No. 62 / 676,722, entitled "Methods for Making YerbaMate Extract Composition", filed on May 25, 2018. For example, the bubble modifier or the bubble modifier compound used in the bubble modifier can be isolated from a plant source containing one or more of monocaffeoylquinic acid, dicaffeoylquinic acid, and their salts. For example, mate biomass and stevia biomass can be used to prepare a suitable bubble modifier. In an exemplary method, a bubble modifier is prepared from commercially available crushed mate biomass. In short, the mate biomass is suspended in 50% (volume / volume) ethanol / water, shaken for at least 1 hour, and the resulting mixture is filtered to obtain an initial extract. The initial extract is diluted with 35% (volume / volume) ethanol / water and filtered again. The refiltered permeate was then applied to a 35% (v / v) ethanol / water equilibrated FPA 53 resin column, and discard the column permeate. Wash the column with 35% (volume / volume) ethanol / water, and discard the column permeate. Then elute the column with a 50% (volume / volume) ethanol / water solution of 10% (weight / volume) FCC grade sodium chloride, and retain the eluent. Blow nitrogen across the surface of the eluent at room temperature to remove ethanol, and reduce the eluent to 1 / 3 of its initial volume. The volume-reduced eluent is then filtered through a 0.2 μm polyethersulfone filter and then decolorized by passing it through a 3 kDa molecular weight cutoff membrane. Retain the decolorized permeate and desalt it by passing it through a nanofiltration membrane. The desalted permeate is then freeze-dried to obtain a bubble modifier, or a composition of a bubble modifier compound that can be used in a bubble modifier. The method is also suitable for obtaining a bubble modifier or a bubble modifier compound for use in a bubble modifier from stevia biomass, and can be suitable for obtaining a bubble modifier or a bubble modifier compound from other plant sources.

[0100] In some aspects, the gas bubble modifier or gas bubble modifier compound used in the gas bubble modifier can be isolated from a plant source. Some examples of plant sources from which the bubble modifier or bubble modifier compound can be isolated include eucommoia ulmoides, honeysuckle, nicotiana benthamiana, artichoke, cardoon, stevia leaf, stevia rebaudiana, monk fruit, coffee, coffee beans, green coffee beans, tea, white tea, yellow tea, green tea, oolong tea, black tea, rooibos, post-fermented tea, bamboo, heather, sunflower, blueberry, cranberry, bilberries, gooseberry, bilberry, lingonberry, cowberry, huckleberry, grape, chicory, eastern purple coneflower, echinacea, European wallweed, upright wallweed, liverwort, greater celandine, bloodroot, European rice stalk, celandine, bloodroot, Common nettle, stinging nettle, nettle), potato, potato leaf, eggplant, aubergine, tomato, cherry tomato, bitter apple, datura, sweet potato, apple, peach, nectarine, cherry, sour cherry, wild cherry, apricot, almond, plum, prune, holly, mate, mate, ilexparaguariensis, guayusa, kudingcha, guarana, cocoa, cocoa bean, cocoa tree, cocoa bean, kola nut, kola nut tree, kola nut, kola nut tree, hornwort, ostrich fern, oriental ostrich fern, bracken, feather fern, oriental ostrich fern, Asian royal fern, royal fern, European fern, phoenix fern, common fern, eagle fern, oriental fern brakenfern), dandelion, algae, seaweed, cloves, cinnamon, Indian bay leaf, nutmeg, laurel, bay leaf, basil, great basil, St. Joseph's weed, thyme, sage leaf, garden sage, common sage, culinary sage, rosemary, oregano, wild marjoram, marjoram, sweet marjoram, knotty marjoram, potted marjoram, dill, anise, star anise, cumin, sweet fennel, tarragon, tarragon, mugwort, licorice, licorice, soybean, soybean, soyabean, soya vean, wheat, common wheat, rice, rapeseed, broccoli, cauliflower, cabbage, Chinese cabbage, kale, collard greens, Brussels sprouts, Brussels sprouts, lindera bark, elderflower, Brazilian bacillus, burdock, valerian and chamomile.In some aspects, the plant source is yerba mate, chicory, rosemary, artichoke, cardoon, and / or stevia.

[0101] In some aspects, the gas modifier can be a blend of gas modifier compounds isolated from more than one plant source. However, it can be a blend of gas modifier compounds isolated from more than one plant source and / or synthetic or fermented hydroxycinnamic acids.

[0102] Some plants can produce a bubble modifier that is rich in one or more of caffeic acid, monocaffeoylquinic acid, and dicaffeoylquinic acid. For example, bubble modifiers isolated from the yerba mate plant (Ilex paraguariensis) and some other plants are naturally rich in dicaffeoylquinic acid.

[0103] Some compounds may adversely affect the flavor or aroma of the gaseous aqueous solution or modified steviol glycoside solution. Certain bubble modifiers such as those prepared from plant extracts do not contain one or more of the compounds shown in Table 1 above the disclosed preferred content levels, or any combination thereof. All preferred content levels are expressed as weight percentages based on dry weight. The content of certain commercially desirable solid (dry) bubble modifiers does not exceed the preferred content levels of the list of compounds listed in Table 1.

[0104] Table 1.

[0105]

[0106]

[0107] A suitable bubble modifier (which may be particularly suitable for use in sugar-free gaseous aqueous solutions) comprises <10 wt%, <5 wt%, <4 wt%, <3 wt%, <2 wt%, <1 wt%, <0.5 wt%, <0.25 wt%, <0.10 wt%, or 0 wt% of steviol glycoside compounds. In selected embodiments, such bubble modifiers are substantially free of steviol glycoside compounds. In particular, in the case where the bubble modifier is derived from stevia (e.g., stevia leaves), reducing the amount of steviol glycoside compounds or excluding steviol glycoside compounds in the bubble modifier allows for more accurate selection of steviol glycoside compounds or other sweeteners to achieve the desired flavor profile of the modified steviol glycoside solution.

[0108] As described above, some compounds can adversely affect the flavor or aroma of the gaseous aqueous solution or modified steviol glycoside solution. A useful bubble modifier comprises a MCQ component, a DCQ component, and less than 0.3% by weight (e.g., 0%) of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or less than 0.05% by weight, e.g., 0% of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, or acetic acid; or less than about 0.05% by weight, e.g., 0% of chlorophyll. In one aspect, the gas bubble modifier is free of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, and malic acid; or free of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate, and acetic acid; or free of chlorophyll.

[0109] Steviol glycosides

[0110] The aqueous solution according to various aspects of the present disclosure may include one or more steviol glycoside compounds and one or more bubble modifier compounds and other compounds. The steviol glycoside compounds generally have the formula

[0111]

[0112] Wherein steviol (R1 and R2=H) is the aglycone backbone, and R1 and R2 can each be hydrogen or one or more sugar moieties. The most common of these sugar moieties are glucose, rhamnose or xylitol, but steviol glycoside compounds have been reported to contain fructose and deoxyglucose sugar moieties.

[0113] Exemplary steviol glycoside compounds that can be used in the solutions described herein include one or more of the following: rebaudioside A (Reb A) (CAS#58543-16-1), rebaudioside B (Reb B) (CAS#58543-17-2), rebaudioside C (Reb C) (CAS#63550-99-2), rebaudioside D (Reb D) (CAS#63279-13-0), rebaudioside E (Reb E) (CAS#63279-14-1), rebaudioside F (Reb F) (CAS#438045-89-7), rebaudioside M (Reb M) (CAS#1220616-44-3), Rubusoside (CAS#63849-39-4), Dulcoside A (CAS#64432-06-0), Rebaudioside I (RebI) (MassBank record: FU000332), Rebaudioside Q (Reb O), Rebaudioside O (Reb O), Rebaudioside N (Reb N) (CAS#1220616-46-5), 1,2-stevioside (CAS#57817-89-7), 1,3-stevioside (Reb G), steviol-1,2-bioside (MassBank record: FU000299), steviol-1,3-bioside, steviol-13-O-glucoside (13-SMG), steviol-19-O-glucoside (19-SMG) and steviol glycoside compounds with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more sugar additions (e.g., glucose, rhamnose and / or xylose), and their isomers. See, for example, "Steviol Glycosides Chemical and Technical Assessment" revised by Jeff Moore (Food Agric. Org.), 82nd JECFA meeting, 2016.

[0114] Exemplary steviol glycosides can include rebaudioside M, rebaudioside D, rebaudioside A, rebaudioside B and / or rebaudioside N. In some aspects, one or more steviol glycoside compounds in steviol glycoside compounds are produced by fermentation by engineered microorganisms. In some aspects, one or more steviol glycoside compounds in steviol glycoside compounds are produced by the biotransformation of enzymes and leaf extracts. For example, rebaudioside D and M can be produced by engineered organisms, and then separated to produce a steviol glycoside composition that is mainly rebaudioside D and rebaudioside M as the main steviol glycoside compound material. In some aspects, one or more steviol glycoside compounds in steviol glycoside compounds are separated from Stevia rebaudiana.

[0115] In some aspects, the amount of rebaudioside D and rebaudioside M included in steviol glycosides may be greater than other steviol glycoside compounds. For example, rebaudioside M and / or rebaudioside D can be present in steviol glycosides in an amount of about 75% by weight or more, about 80% by weight or more, about 80% by weight or more, preferably about 90% by weight or more, about 92.5% by weight or more, or 95% by weight or more of the total amount of steviol glycoside compounds in the composition. Rebaudioside M can be the main steviol glycoside compound in steviol glycosides, and can be present in an amount ranging from about 45% by weight to about 70% by weight, about 50% by weight to about 65% by weight, or about 52.5% by weight to about 62.5% by weight of the total amount of steviol glycoside compounds in the composition, for example. The amount of rebaudioside D may be less than rebaudioside M, such as in an amount ranging from about 25% to about 50%, about 30% to about 45%, or about 32.5% to about 42.5% of the total amount of steviol glycoside compounds in the composition.

[0116] Steviol glycosides may optionally include lesser amounts of steviol glycoside compounds other than rebaudioside D and rebaudioside M. For example, the composition may include one or more of rebaudioside A, rebaudioside B, or stevioside in an amount of about 1% by weight or less, about 0.5% by weight or less, or about 0.25% by weight or less of the total amount of steviol glycoside compounds in the composition.

[0117] Modified steviol glycoside solution

[0118] The amount of steviol glycoside in the modified steviol glycoside solution can change according to the desired purposes.For example, steviol glycoside can be at least 20ppm, preferably at least 50ppm, for example, about 50ppm to about 1000ppm, about 50ppm to about 10000ppm (1 (weight)%), about 50ppm to about 100000ppm (10 (weight)%), about 50ppm to about 200000ppm (20 (weight)%), or about 50ppm to about 300000ppm (30 (weight)%) concentration is present in the modified steviol glycoside solution.In some aspects, steviol glycoside exists with the concentration of at least 10ppm, 100ppm, 200ppm, 300ppm, 400ppm, 500ppm, 600ppm, 700ppm, 800ppm, 900ppm or 1000ppm.

[0119] In some modified steviol glycoside solutions, steviol glycosides are present at a content that can serve as a flavoring agent (e.g., serving as a sweetness enhancer) but below the content at which sweetness will be detected. Such modified steviol glycoside solutions may have a steviol glycoside concentration of about 10ppm-80ppm, about 10ppm-65ppm, about 10ppm-50ppm, about 10ppm-40ppm, about 15ppm-65ppm, about 15ppm-50ppm, about 15ppm-40ppm, or about 20ppm-30ppm. Specific examples of modified steviol glycoside solutions in which steviol glycosides are present at a flavoring agent content include a total of 15ppm-80ppm (e.g., 16ppm-65ppm) of rebaudioside M and rebaudioside A, or about 20ppm-24ppm of rebaudioside M.

[0120] Other modified steviol glycoside solutions can have a higher steviol glycoside concentration that can provide a noticeable sweet taste, such as about 100ppm to about 5000ppm, about 200ppm to about 5000ppm, 300ppm to about 5000ppm, 400ppm to about 5000ppm, 500ppm to about 5000ppm, 600ppm to about 5000ppm, 700ppm to about 5000ppm, 800ppm to about 5000ppm, 900ppm to about 5000ppm, or 1000ppm to about 5000ppm. In other aspects, steviol glycosides are present in a concentration of about 1000ppm to about 5000ppm, about 2000ppm to about 5000ppm, about 3000ppm to about 5000ppm, or about 4000ppm to about 5000ppm. The steviol glycosides may be present in the modified steviol glycoside solution at a concentration equal to or greater than about 10 ppm, 100 ppm, 200 ppm, 300 ppm, 400 ppm, 500 ppm, 600 ppm, 700 ppm, 800 ppm, 900 ppm, 1000 ppm, 2000 ppm, 3000 ppm, 4000 ppm, 5000 ppm, 6000 ppm, 7000 ppm, 8000 ppm, 9000 ppm, 10000 ppm, 20000 ppm, 30000 ppm, 40000 ppm, 50000 ppm, 60000 ppm, 70000 ppm, 80000 ppm, 90000 ppm, 100000 ppm, 200000 ppm or 300000 ppm.

[0121] On the other hand, steviol glycosides are present in the modified steviol glycoside solution at a concentration ranging from about 10ppm to about 1,000ppm, more specifically about 10ppm to about 800ppm, about 50ppm to about 800ppm, about 50ppm to about 600ppm, or about 200ppm to about 500ppm. In some commercially available embodiments, such as in ready-to-drink beverages, the steviol glycoside concentration in the modified steviol glycoside solution may be 100ppm to 1600ppm, preferably 200ppm to 1000ppm, or more preferably 400ppm to 800ppm.

[0122] The modified steviol glycoside solution may have any suitable pH, such as a pH between 0 and 7, between 1 and 6, or between 1.5 and 4.

[0123] In modified steviol glycoside solution, the amount of bubble modifier can change according to desired purposes.For example, bubble modifier can be present in modified steviol glycoside solution with about 1ppm to about 1000ppm, about 1ppm to about 10000ppm, about 1ppm to about 100000ppm, about 1ppm to about 200000ppm or about 1ppm to about 300000ppm.In some aspects, bubble modifier can be present in modified steviol glycoside solution with about 100ppm to about 5000ppm, about 200ppm to about 5000ppm, 300ppm to about 5000ppm, 400ppm to about 5000ppm, 500ppm to about 5000ppm, 600ppm to about 5000ppm, 700ppm to about 5000ppm, 800ppm to about 5000ppm, 900ppm to about 5000ppm or 1000ppm to about 5000ppm. In some aspects, the gas bubble modifier can be present in the modified steviol glycoside solution at about 1000 ppm to about 5000 ppm, about 2000 ppm to about 5000 ppm, about 3000 ppm to about 5000 ppm, or about 4000 ppm to about 5000 ppm. In some aspects, the bubble modifier can be equal to or greater than about 10ppm, 100ppm, 200ppm, 300ppm, 400ppm, 500ppm, 600ppm, 700ppm, 800ppm, 900ppm, 1000ppm, 2000ppm, 3000ppm, 4000ppm, 5000ppm, 6000ppm, 7000ppm, 8000ppm, 9000ppm, 10000ppm, 20000ppm, 30000ppm, 40000ppm, 50000ppm, 60000ppm, 70000ppm, 80000ppm, 90000ppm or 100000ppm present in the modified steviol glycoside solution. In some aspects, the bubble modifier can be equal to or greater than about 200000ppm present in the modified steviol glycoside solution. In some aspects, the bubble modifier may be present in the modified steviol glycoside solution at equal to or greater than about 300,000 ppm.

[0124] In aqueous solution, whether a modified steviol glycoside solution or a gaseous aqueous solution, the bubble modifier compound can be present in acid form or salt form, for example, as a quaternary ammonium salt, sodium salt, potassium salt, lithium salt, magnesium salt or calcium salt, or a combination of such salts. In aqueous solution, the bubble modifier may or may not dissociate, for example, part or all of the potassium salt of the acidic bubble modifier compound may dissociate into potassium cations and anions.

[0125] In the modified steviol glycoside solution, the ratio of bubble modifier to steviol glycoside can be changed. In the modified steviol glycoside solution, the ratio of bubble modifier to steviol glycoside can be changed as needed or required, so that it can effectively reduce the bubble size in the liquid matrix of the modified steviol glycoside solution or improve the foaming characteristics of the modified steviol glycoside solution. For example, the ratio of bubble modifier to steviol glycoside can be about 0.1 to 10. In some aspects, the ratio of bubble modifier to steviol glycoside can be between about 0.1 to 5, between about 0.5 to 4 or between about 1 to 3.

[0126] In some aspects, the modified steviol glycoside solution mainly comprises water. The modified steviol glycoside solution can also be buffered with any suitable buffer system, which includes but is not limited to one or more buffers, such as phosphate, citrate, ascorbate, lactate, acetate, etc. The buffer can include an anion component of 1mM-1000mM. In other aspects, the modified steviol glycoside solution includes citrate / phosphate buffer. In some aspects, citrate / phosphate buffer can have a pH of 2 to 4.

[0127] In some aspects, the modified steviol glycoside solution may include additives, flavoring agents, pigments, fillers, bulking agents and other ingredients. A wide variety of such ingredients are known for various applications.

[0128] In one aspect, the modified steviol glycoside solution is a beverage product comprising steviol glycoside and a bubble modifier. As used herein, a "beverage product" is a ready-to-drink beverage, a beverage concentrate, a beverage syrup, a frozen beverage, or a powdered beverage. Suitable ready-to-drink beverages include aerated beverages and non-aerated beverages. Aerated beverages include, but are not limited to, carbonated beverages and nitrogen-containing beverages, such as energy-enhanced soda, cola, flavored soda such as lemon-lime flavored soda and orange-flavored soda, ginger ale, soft drinks, Maggen root beer, vanilla drinks, and energy-enhanced soda. Non-carbonated beverages include, but are not limited to, fruit juices, fruit-flavored juices, fruit drinks, nectars, vegetable juices, vegetable-flavored juices, sports drinks, energy drinks, energy water drinks, vitamin-fortified waters, near-water drinks (e.g., water with natural or synthetic flavors), coconut water, tea drinks (e.g., black tea, green tea, Rooibos tea, oolong tea), coffee, cocoa drinks, beverages containing dairy ingredients (e.g., dairy drinks, coffee containing dairy ingredients, milk coffee, milk tea, fruit dairy drinks), beverages containing cereal extracts, milk shakes, and combinations thereof.

[0129] Beverage concentrates and beverage syrups can be prepared with an initial volume of a liquid base (e.g., water) and the desired beverage ingredients. A full strength beverage is then prepared by adding an additional volume of water.

[0130] In some aspects, the beverage concentrate can be used as a sparge syrup for preparing gaseous aqueous solutions, such as carbonated soda beverages prepared in soda fountains.The modified steviol glycoside solution can comprise primarily water, but can also comprise alcohol.

[0131] The modified steviol glycoside solution may further comprise a buffer, such as a citrate / phosphate buffer. The citrate / phosphate buffer may have a pH of 1.5 to 4, such as 2-4.

[0132] In some aspects, before being used as a beverage, the beverage concentrate solution is diluted with a stream of gasified water to form a gaseous aqueous solution when dispensing the beverage, such as diluting the beverage concentrate solution in a cold drink cabinet. The volume of the final diluted beverage can be much larger than the concentrate, for example, 5 to 7 times (in the case of a typical spray syrup) or 80 to 100 times (in the case of a typical liquid enhancer) the volume of the beverage concentrate solution in the beverage. The bubble modifier can be present in the beverage concentrate in an amount that effectively improves the foaming properties when dispensing the beverage. Such beverage concentrates that can be used as spray syrups can have about 1500ppm to 4200ppm of steviol glycosides and 1800ppm to 5400ppm (e.g., 1800ppm-3000ppm) of bubble modifier. If the beverage concentrate is used as a liquid enhancer diluted 80-100 times in the final beverage, it may have about 4800 to 20,000 ppm (e.g., 6000-10,000 ppm) of steviol glycosides and 2400 to 20,000 ppm (e.g., 3000-10,000 ppm) of bubble modifier.

[0133] The modified steviol glycoside solution can be non-alcoholic or alcoholic. Non-alcoholic modified steviol glycoside solutions (e.g., non-alcoholic beer) may contain less than 0.5% by weight, preferably less than 0.2%, less than 0.1% by weight, or less than 0.05% by weight (e.g., 0%) of ethanol. Alcoholic modified steviol glycoside solutions may contain more than 0.5% by weight of alcohol, such as 2% to 60% by weight of alcohol. However, some bubble modifier compounds may not be easily soluble in alcohol. Alcoholic modified steviol glycoside solutions may have bubble modifiers up to the solubility limit of some or all of the bubble modifier compounds in their component bubble modifier compounds. In order to keep some available bubble modifiers in solution, the alcohol content of the alcoholic modified steviol glycoside solution may be maintained at a relatively low level of 1% to 5% by weight of alcohol.

[0134] The bubble modifier in the aqueous solution without steviol glycoside compound does not have much effect on the foaming behavior of such aqueous solution. The steviol glycoside compound in the aqueous solution without bubble modifier does affect the foaming behavior of such aqueous solution. However, we found that the modified solution containing steviol glycoside (e.g., the sweetening level of steviol glycoside compound) and the bubble modifier described herein has a significant effect on the foaming behavior.

[0135] Such modified steviol glycoside solutions with altered foam properties can form more foam, more stable foam and / or foam with reduced bubble size. This can be commercially attractive in many applications. For example, a larger foam volume and / or a more stable foam can be particularly visually attractive for carbonated beverages such as root beer (root beer is beer that is usually gasified with carbon dioxide or increasingly gasified with nitrogen or a combination of carbon dioxide and nitrogen), and give non-alcoholic beers a thicker "foam head" so they look more like regular beer.

[0136] In one aspect, according to the modified steviol glycoside solution of the present disclosure, there is at least 20ppm, preferably at least 50ppm or at least 100ppm of steviol glycoside and a bubble modifier at a concentration of 50ppm to 1600ppm. Compared with the aqueous solution without bubble modifier, the concentration of bubble modifier in the modified steviol glycoside solution should effectively reduce the average bubble diameter in the foam. Foam can be naturally formed by the effervescence of the gas dissolved in the modified steviol glycoside solution (if it is a gasified aqueous solution). Foam can be formed separately or simultaneously with effervescence in other ways. For example, foam can be formed by mixing the modified steviol glycoside solution with carbonated water in a cold drink cabinet, by stirring (for example, mixing or shaking in a blender) or by passing gas bubbling into the modified steviol glycoside solution.

[0137] The standardized test protocol for determining whether a modified steviol glycoside solution has an amount of bubble modifier that is effective in changing the foam in a desired manner (e.g., by reducing the size of bubbles in the foam by at least 5%) is referred to herein as the Foamscan test. The test is performed on a foam scanning instrument Foamscan commercially available from Teclis Scientific. Foamscan analyzes foam behavior by injecting or "bubbling" a gas into a certain volume of liquid, measuring the volume of the foam generated by the bubbled gas, the stability of the foam, and / or visually characterizing the foam. Foamscan is run in the following manner: air is delivered to 60 ml of a modified steviol glycoside solution at an airflow rate of 150 ml / min for 60 seconds. The temperature of the modified steviol glycoside solution should be 15.6°C (60°F), and the test should be performed at an ambient pressure of 1 atmosphere.

[0138] As explained in Example 1 below, a Foamscan instrument running a Foamscan test can determine the average area of ​​bubbles in a foam by taking a digital photograph of the foam and analyzing the image. The photograph is two-dimensional, so the bubble size is measured as the area of ​​the bubble in the photograph. To determine the average diameter of the bubble, it can be assumed that the bubble approximates a sphere, which will be reflected as a circle in two dimensions. The diameter can be easily derived from the area of ​​the bubble in the photograph:

[0139]

[0140] A useful modified steviol glycoside solution has an amount of bubble modifier that effectively reduces the average bubble diameter in the foam in the presence of steviol glycosides compared to the foam bubbles in a control aqueous solution without the bubble modifier (i.e., an aqueous solution with the same composition but omitting the bubble modifier). In a Foamscan test, the average bubble diameter in the modified steviol glycoside solution is advantageously at least 5%, at least 10%, or at least 15%, preferably at least 20%, at least 25%, at least 30%, at least 40%, or at least 50% smaller than the average bubble diameter in the control solution.

[0141] The Foamscan instrument also measures foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and volume stability (t 泡沫1 / 2 ). Example 1 defines each of these measurement results.

[0142] Modified steviol glycoside solutions suitable for certain commercial applications may have a foam capacity (defined below) of at least 0.8, which is determined using the maximum foam volume achieved in a sample run. Alternatively, the foam capacity may be determined using the volume measured 30 seconds after gas delivery is terminated (referred to as FC 30 ) is determined. Some such solutions may have a foam capacity or FC of at least 0.9, at least 1.0, at least 1.1, or at least 1.2. 30 .

[0143] Viewed in another way, the foam capacity or FC of the modified steviol glycoside solution according to aspects of the present disclosure is 30 The foam capacity or FC of the control aqueous solution without bubble modifier can be compared respectively. 30 At least 40% greater, preferably at least 60%, at least 70%, at least 75% or at least 80% greater.

[0144] The Foamscan test does not directly characterize the foam that may form on a solution in use, such as when dispensing a carbonated cola from a soda fountain or mixing a frozen beverage in a blender. Nevertheless, it is believed to provide valuable quantitative results about the foaming characteristics of a beverage that can generally be correlated to real-world foaming behavior in use.

[0145] As described in the following examples, still beverages with different compositions, including flavored distilled water and unflavored distilled water, were analyzed using the Foamscan test. Distilled water samples containing steviol glycosides and bubble modifiers (SG+BM), steviol glycosides but no bubble modifiers (SG), and bubble modifiers but no steviol glycosides (BM) were prepared. The average final foam volume (V 泡沫 ) was 82, the average final foam volume of the BM sample was only 19, and the average final foam volume of the SG+BM sample was 161. This shows that there is a significant unexpected synergy between the bubble modifier and the steviol glycoside. In certain aspects, as measured using the Foamscan test, the V in the modified steviol glycoside solution is 泡沫 Compared with the first control solution having the same composition but without the bubble modifier, V 泡沫 , compared with the V of the second control solution having the same composition but without steviol glycosides. 泡沫 , or V of both the first control and the second control 泡沫 At least 20% higher, at least 25% higher or at least 30% higher, preferably at least 40% higher, at least 50% higher or at least 60% higher.

[0146] Vaporized aqueous solution

[0147] Other aspects of the present disclosure provide a gasified aqueous solution comprising a bubble modifier but may or may not contain steviol glycosides. Examples of gaseous aqueous solutions that do not contain steviol glycosides include flavored carbonated water and conventional ready-to-drink carbonated beverages, such as cola or energy drinks sweetened with sugar, aspartame or other non-steviol glycoside sweeteners.

[0148] Gaseous aqueous solutions can be gasified with any gas suitable for the intended purpose. For example, beverages are often gasified with carbon dioxide and / or nitrogen.

[0149] The amount of gas dissolved in the gaseous aqueous solution can vary widely, but should be sufficient to cause the gaseous aqueous solution to effervesce at STP. The content of the gas in the modified steviol glycoside solution can be at least 50% higher than the equilibrium saturation value of the gas at STP, preferably at least 100%, at least 200% or at least 300% higher. Nitrogen has limited solubility in most aqueous solutions. Therefore, it may be desirable to include nitrogen and carbon dioxide, for example, wherein the nitrogen is at its maximum solubility, and the remaining portion of the desired bubbles comes from CO2.

[0150] The bubble modifier may be present in an amount that effectively reduces the average diameter of bubbles in the matrix of the modified steviol glycoside solution or bubbles that may condense on the surface of a container for the modified steviol glycoside solution relative to a control solution without the bubble modifier (i.e., an aqueous solution having the same composition but omitting the bubble modifier). In one aspect, "in the matrix" is intended to mean bubbles within the bulk of the solution, rather than bubbles in the foam carried by the solution.

[0151] The average bubble size reduction can be maintained for a long time or even until one of the modified steviol glycoside solution and the control solution no longer effervescent. However, the comparison of bubble diameter at a fixed time point can allow more reproducible results. Therefore, in one aspect, the bubble size in the modified steviol glycoside solution and the control is measured within 1 minute after the effervescence starts under STP. Even if it is not impossible, it is also difficult to measure the bubble size in a tank or bottle. Therefore, the gasified canned or bottled beverage can be poured into a container more suitable for measuring bubble size, and the effervescent start time is set to the time when the beverage is poured into the container. Some gaseous aqueous solutions can be formed by injecting gas into the solution, for example, by injecting nitrogen in the pipeline through which the solution flows with a restriction plate, or by (for example) as in a conventional cold drink cabinet, adding gasified water (or other suitable liquids) to form. In such cases, the effervescent start time is set to the time when the solution is dispensed into the container for measurement.

[0152] Although bubbles in a gaseous solution may arise from other sources, such as stirring or bubbling, the bubbles measured to determine the average diameter should be those that are "inherent" to the gaseous aqueous solution, ie, bubbles that arise from the gas dissolved in the solution.

[0153] The bubbles formed in the gaseous aqueous solution containing the bubble modifier may have other useful properties. For example, the bubbles in the gaseous aqueous solution containing the bubble modifier may persist longer in the solution matrix or on the surface of the container than the same gaseous aqueous solution without the bubble modifier. The time for the bubbles to be released from the surface of the container may also be slower in the gaseous aqueous solution containing the bubble modifier than the same gaseous aqueous solution without the bubble modifier. This may make the gaseous aqueous beverage containing the bubble modifier more visually attractive because it appears to have more bubbles than the same beverage without the bubble modifier.

[0154] method

[0155] A method for reducing the size of bubbles formed by gasifying an aqueous solution, the method comprising adding a bubble modifier to the aqueous solution after the aqueous solution is gasified, or more advantageously before the aqueous solution is gasified, or while the aqueous solution is gasified.

[0156] A method for increasing the volume, volume stability, foam capacity, foam expansion and / or foam density of foam produced from an aqueous solution, the method comprising adding a bubble modifier and steviol glycosides to the aqueous solution after, or more advantageously before, or as the aqueous solution is vaporized.

[0157] Example

[0158] The following examples are provided to illustrate the present disclosure but are not intended to limit the scope thereof. Unless otherwise indicated, all parts and percentages are by weight.

[0159] Example 1 :

[0160] Solution 1

[0161] Scheme 1 uses a fixed air bubbling time of 40 seconds or 60 seconds to analyze the characteristics of the corresponding samples. In short, the measurement is performed using a FoamscanTM instrument (Teclis Scientific, Marseille France). A single liquid sample with an initial liquid volume of 60 ml is loaded into the vertical glass cylinder of the FoamscanTM instrument. Air is then bubbled into the liquid sample at a gas flow rate of 150 ml / min for 40 seconds or 60 seconds to generate foam. The generated foam expands above the surface of the liquid sample in the vertical glass cylinder. From the beginning of air injection until the generated foam is completely attenuated, the foam generation and foam attenuation are monitored in real time. The volume of the generated foam is measured in real time. The foam conductivity coefficient is also measured in real time.

[0162] Determination of foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and foam volume stability (t 泡沫1 / 2 ).

[0163] The foam capacity (FC) at time t is calculated as the total volume of foam at time t (Vt(foam)) divided by the total volume of bubbling gas (Vt(gas)) as follows:

[0164]

[0165] The foam maximum density (MD) is calculated using the initial volume of liquid (Vi(liquid)), the final volume of liquid (Vf(liquid)), and the final volume of foam (Vf(foam)) in the following manner:

[0166]

[0167] The foam expansion (FE) is calculated using the final volume of foam (Vf(foam)), the initial volume of liquid (Vi(liquid)) and the final volume of liquid (Vf(liquid)) in the following manner:

[0168]

[0169] The final foam capacity (FC) is calculated as the final volume of foam (Vf(foam)) divided by the final volume of bubbling gas (Vf(gas)) as follows:

[0170]

[0171] Volume stability of foam (t 泡沫1 / 2 ) is determined as the time required for the foam volume to decay by half. The highest measured volume of the foam is used as the final volume of the foam (Vf(foam)). The total amount of bubbling gas is used as the final volume of the injected gas (Vf(gas)). The initial volume of the liquid sample loaded into the instrument is used as the initial volume of the liquid (Vi(liquid)). The volume of the liquid when the volume of the foam reaches its highest measured value is the final volume of the liquid (Vf(liquid)). The final foam conductivity is measured when the generated foam reaches its highest volume.

[0172] Solution 2

[0173] Scheme 2 uses air bubbling to generate a fixed volume of foam to analyze the characteristics of the corresponding sample. In short, the measurement was performed using a FoamscanTM foam analyzer (Teclis Scientific, Marseille France). A sample with an initial liquid volume of 60 ml was loaded into the vertical glass cylinder of the Foamscan instrument. Air was then bubbled into the liquid sample at a gas flow rate of 150 ml / min to generate foam. The generated foam expanded above the surface of the liquid sample, and air bubbling was continued until 250 ml of foam was generated. From the beginning of air bubbling until the generated foam completely decayed, foam generation and foam decay were monitored in real time. The volume of the generated foam was measured in real time. The foam conductivity was also measured in real time. The foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and volume stability (t 泡沫1 / 2), as described in Scheme 1.

[0174] Example 2 :

[0175] Sample preparation

[0176] Samples corresponding to low-calorie beverages were prepared using a combination of steviol glycosides, bubble modifiers, citrate buffer and / or flavoring agents. High-purity rebaudioside M (>95% total steviol glycoside compounds (JECFA 9+ rebaudioside M), which contained about 87.5% rebaudioside M and about 10.4% rebaudioside D) was used. As described above, the bubble modifier was a plant extract derived from yerba mate (Cargill batch number YM20180628). The bubble modifier contained greater than 40% dicaffeoylquinic acid and / or its salt. Samples A, B, C, D and E had steviol glycoside concentrations, bubble modifier concentrations and flavors as shown in Table 1.

[0177] Table 1.

[0178]

[0179]

[0180] Samples A, B, C, D, and E were prepared with the components shown in Table 2 and water was added to volume. The pH of samples A, B, C, D, and E were each adjusted with an acidic citrate buffer system as described below.

[0181] Table 2.

[0182]

[0183] Sample A was prepared by preheating water to 65°C in an amount of about 20% of the desired final volume, adding the corresponding amount of Reb M to the preheated water, covering, and allowing the Reb M to dissolve while stirring on a stir plate with a magnetic stir bar. After the Reb M was dissolved, the remaining ingredients were added in the following order with stirring: sodium benzoate, potassium citrate, and citric acid. Water (20°C) was added to the final desired volume, and the sample was stirred until completely dissolved. The sample had a pH of 3.2. The sample was transferred to a 12 oz fluid glass bottle, labeled and sealed.

[0184] Sample B was prepared by preheating water to 40°C in an amount of approximately 20% of the desired final volume, adding the corresponding amount of bubble modifier to the preheated water, covering, and allowing the bubble modifier to dissolve while stirring on a stir plate with a magnetic stir bar. After the bubble modifier was dissolved, the remaining ingredients were added in the following order with stirring: sodium benzoate, potassium citrate, and citric acid. Water (20°C) was added to the final desired volume, and the sample was stirred until completely dissolved. The sample had a pH of 3.2. The sample was transferred to a 12 oz fluid glass bottle, labeled and sealed.

[0185] Sample C was prepared by preheating water to 40°C in an amount of about 20% of the desired final volume, adding the corresponding amount of bubble modifier to the preheated water, covering, and allowing the bubble modifier to dissolve while stirring on a stir plate with a magnetic stir bar. The corresponding amount of Reb M was then added and stirred until dissolved. After Reb M was dissolved, the remaining ingredients were added in the following order with stirring: sodium benzoate, potassium citrate, and citric acid. Water (20°C) was added to the final desired volume and the sample was stirred until completely dissolved. The sample had a pH of 3.2. The sample was transferred to a 12 oz fluid glass bottle, labeled and sealed.

[0186] Sample D was prepared by preheating water to 40°C in an amount of about 20% of the desired final volume, adding the corresponding amount of bubble modifier to the preheated water, covering, and allowing the bubble modifier to dissolve while stirring on a stir plate with a magnetic stir bar. The corresponding amount of Reb M was then added and stirred until dissolved. After the Reb M was dissolved, the remaining ingredients were added in the following order with stirring: sodium benzoate, potassium citrate, citric acid, and lemon-lime flavor. Water (20°C) was added to the final desired volume and the sample was stirred until completely dissolved. The sample had a pH of 3.2. The sample was transferred to a 12 oz fluid glass bottle, labeled and sealed.

[0187] Sample E was prepared by preheating water to 40°C in an amount of approximately 20% of the desired final volume, adding the corresponding amount of bubble modifier to the preheated water, covering, and allowing the bubble modifier compound to dissolve while stirring on a stir plate with a magnetic stir bar. The corresponding amount of Reb M was then added and stirred until dissolved. After the Reb M was dissolved, the remaining ingredients were added in the following order with stirring: sodium benzoate and cola flavor. Phosphoric acid was added until a pH of 2.9-3.1 was reached. Water (20°C) was added to the final desired volume, and the sample was stirred until completely dissolved. The sample had a pH between 2.9 and 3.1. The sample was transferred to a 12 oz fluid glass bottle, labeled and sealed.

[0188] Example 3 :

[0189] Samples A, B, C, D and E were prepared as described in Example 2. Protocol 1 was performed with a bubbling rate of 150 ml / min using a 40 s air bubbling time to analyze the foam properties of each of the individual samples AE. Several measurements were performed on each individual sample. The initial liquid volume was 60 ml. Air was used as the bubbling gas. The foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and volume stability (t 泡沫1 / 2 ). The final foam conductivity was also measured.

[0190] The results for Protocol 1 (40 seconds air sparging) are shown in Table 3.

[0191] Table 3 - Protocol 1, 40 sec air sparging

[0192]

[0193] The final foam volumes of sample A (Reb M) and sample B (bubble modifier) ​​were 66 ml and 23 ml, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon lime flavor) and E (Reb M, bubble modifier, cola flavor) had final foam volumes of 118 ml, 118 ml and 119 ml, respectively. Each sample in the sample containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam volume compared to the sample with only steviol glycosides. Each sample in the sample containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam volume compared to the sample with only bubble modifiers. The final foam volume of the sample containing both steviol glycosides and bubble modifiers was about twice the final foam volume of the sample with only steviol glycosides. The final foam volume of the sample containing both steviol glycosides and bubble modifiers was about five times the final foam volume of the sample with only bubble modifiers.

[0194] The final foam capacities of sample A (Reb M) and sample B (bubble modifier) ​​were 0.68 and 0.23, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor), and E (Reb M, bubble modifier, cola flavor) had final foam capacities of 1.22, 1.22, and 1.23, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam capacity compared to the sample with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam capacity compared to the sample with only bubble modifiers. The final foam capacity of the samples containing both steviol glycosides and bubble modifiers was almost twice the final foam capacity of the samples with only steviol glycosides. The final foam capacity of the sample containing both steviol glycosides and the bubble modifier was about five times the final foam capacity of the sample with only the bubble modifier.

[0195] The final foam conductivities of sample A (Reb M) and sample B (bubble modifier) ​​were 42.5 μS and 0.125 μS, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor), and E (Reb M, bubble modifier, cola flavor) had final foam conductivities of 58.242 μS, 65.47 μS, and 80.41 μS, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam conductivities compared to the samples with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam conductivities compared to the samples with only bubble modifiers. The final foam capacity of the samples containing both steviol glycosides and bubble modifiers was increased compared to the final foam conductivities of the samples with only steviol glycosides.

[0196] The foam volume stability of sample A (Reb M) and sample B (bubble modifier) ​​were 14 s and 7.5 s, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor) and E (Reb M, bubble modifier, cola flavor) had foam volume stability of 104 s, 180 s and 221 s, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in foam volume stability compared to the sample with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in foam volume stability compared to the sample with only bubble modifiers. The foam volume stability of the samples containing both steviol glycosides and bubble modifiers was about 7 to 16 times longer than the foam volume stability of the samples with only steviol glycosides. The foam volume stability of the samples containing both steviol glycosides and bubble modifiers was about 13 to 29 times longer than the foam volume stability of the samples with only bubble modifiers. The volume stability of samples D and E was longer than the foam volume stability of the sample without flavor (sample C). The foam volume stability of sample E (cola flavor) (221 s) was longer than the foam volume stability of sample D (lemon-lime flavor) (180 s).

[0197] Example 4 :

[0198] Samples A, B, C, D and E were prepared as described in Example 2. Protocol 1 was performed with a bubbling rate of 150 ml / min using a 60 s air bubbling time to analyze the foam properties of each of the individual samples AE. Several measurements were performed on each individual sample. The initial liquid volume was 60 ml. Air was used as the bubbling gas. The foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and volume stability (t 泡沫1 / 2 ). The final foam conductivity was also measured.

[0199] The results for Protocol 1 (60 seconds air sparging) are shown in Table 4.

[0200] Table 4 - Protocol 1, 60 sec air sparging

[0201]

[0202] The final foam volumes of sample A (Reb M) and sample B (bubble modifier) ​​were 82 ml and 19 ml, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor) and E (Reb M, bubble modifier, cola flavor) had final foam volumes of 161 ml, 174 ml and 170 ml, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam volume compared to the sample with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam volume compared to the sample with only bubble modifiers. The final foam volume of the sample containing both steviol glycosides and bubble modifiers was about twice the final foam volume of the sample with only steviol glycosides. The final foam volume of the sample containing both steviol glycosides and bubble modifiers exceeded 8 times the final foam volume of the sample with only bubble modifiers.

[0203] The final foam capacities of sample A (Reb M) and sample B (bubble modifier) ​​were 0.56 and 0.13, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor), and E (Reb M, bubble modifier, cola flavor) had final foam capacities of 1.097, 1.19, and 1.153, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam capacity compared to the sample with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam capacity compared to the sample with only bubble modifiers. The final foam capacity of the samples containing both steviol glycosides and bubble modifiers was about twice the final foam capacity of the samples with only steviol glycosides. The final foam capacity of the sample containing both steviol glycosides and the bubble modifier was more than 8 times the final foam capacity of the sample with only the bubble modifier.

[0204] The final foam conductivities of sample A (Reb M) and sample B (bubble modifier) ​​were 443.600 μS and 0.192 μS, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor), and E (Reb M, bubble modifier, cola flavor) had final foam conductivities of 47.981 μS, 76.210 μS, and 67.613 μS, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam conductivities compared to the sample with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in final foam conductivities compared to the sample with only bubble modifiers. The final foam conductivities of the samples containing both steviol glycosides and bubble modifiers were increased compared to the final foam capacity of the samples with only steviol glycosides.

[0205] The foam volume stability of sample A (Reb M) and sample B (bubble modifier) ​​was 17 s and 11 s, respectively. Samples C (Reb M, bubble modifier), D (Reb M, bubble modifier, lemon-lime flavor) and E (Reb M, bubble modifier, cola flavor) had foam volume stability of 49 s, 90 s and 53 s, respectively. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in foam volume stability compared to the sample with only steviol glycosides. Each of the samples containing both steviol glycosides and bubble modifiers showed a surprising increase in foam volume stability compared to the sample with only bubble modifiers. The foam volume stability of the samples containing both steviol glycosides and bubble modifiers was about 2 to 5 times longer than the foam volume stability of the samples with only steviol glycosides. The foam volume stability of the samples containing both steviol glycosides and bubble modifiers was about 4 to 8 times longer than the foam volume stability of the samples with only bubble modifiers. The volume stability of samples D and E was longer than the foam volume stability of the sample without flavor (sample C). The foam volume stability of sample D (cola flavor) (90 s) was longer than that of sample E (lemon-lime flavor) (53 s).

[0206] Example 5 :

[0207] Samples A, B, C, D and E were prepared as described in Example 2. Protocol 2 was performed using an air bubbling rate of 150 ml / min to obtain a volume of 250 ml of generated foam to analyze the foam properties of each of the individual samples AE. Several measurements were made for each individual sample. The initial liquid volume was 60 ml. Air was used as the bubbling gas. The foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and volume stability (t 泡沫1 / 2 ). The final foam conductivity was also measured.

[0208] The results of Scheme 2 are shown in Table 5.

[0209] Table 5 - Solution 2, 250ml foam height

[0210]

[0211]

[0212] As shown in Table 5, due to insufficient foaming, samples A (Reb M), B (bubble modifier) ​​and C (Reb M, bubble modifier) ​​did not generate complete data. Sample A only reached a final foam volume of 90 ml after a total gas bubbling time of 68 seconds. Sample B could not be tested due to very little foam generated. Sample C only reached a final foam volume of 195 ml. Therefore, although the foam properties of samples A, B and C were measured, it is difficult to compare these foam properties with the foam properties of samples D and E. Samples D and E generated enough foam to reach a fixed foam volume of 250 ml. The final foam capacities of samples D and E were 1.17 and 1.1, respectively. The final foam conductivity coefficients of samples D and E were 81.436 μS and 101.518 μS, respectively. The foam volume stability of samples D and sample E was 66 s and 23 s, respectively.

[0213] Example 6 :

[0214] In each of Examples 3-5, the bubble characteristics were observed by digital photography. Digital photos of the foam bubbles in the corresponding sample were taken at regular intervals at the start of air bubbling, throughout the air bubbling process, and during the decay of the generated foam. Digital photos of samples A, C, D, and E were recorded. Digital photos of sample B were not taken because very little foam was generated in the analysis of sample B and the foam decayed quickly. Figure 1-4C Digital photographs of samples A, C, D and E are shown. Figure 1Digital photographs of bubbles of Sample A in Example 3 after 35 seconds, 40 seconds, 45 seconds, 50 seconds, 55 seconds, 60 seconds, 65 seconds, 70 seconds, 75 seconds, 80 seconds and 85 seconds are shown. Figure 2A Digital photographs of bubbles of Sample C in Example 3 after 5 seconds, 10 seconds, 15 seconds, 50 seconds, 65 seconds and 75 seconds are shown. Figure 2B Digital photographs of bubbles of Sample C in Example 4 after 5 seconds, 10 seconds, 15 seconds, 20 seconds, 90 seconds and 150 seconds are shown. Figure 2C Digital photographs of bubbles of Sample C in Example 5 after 5 seconds, 10 seconds, 15 seconds and 20 seconds are shown. Figure 3A Digital photographs of bubbles of Sample D in Example 3 after 5 seconds, 10 seconds, 15 seconds, 55 seconds, 150 seconds and 185 seconds are shown. Figure 3B Digital photographs of bubbles of Sample D in Example 4 after 5 seconds, 10 seconds, 15 seconds, 30 seconds, 35 seconds and 40 seconds are shown. Figure 3C Digital photographs of bubbles of Sample D in Example 5 after 5 seconds, 10 seconds, 15 seconds, 30 seconds, 35 seconds and 40 seconds are shown. Figure 4A Digital photographs of bubbles of Sample E in Example 3 after 5 seconds, 10 seconds, 15 seconds, 150 seconds, 300 seconds and 450 seconds are shown. Figure 4B Digital photographs of bubbles of Sample E in Example 4 after 5 seconds, 10 seconds, 15 seconds, 30 seconds, 35 seconds and 40 seconds are shown. Figure 4C Digital photographs of bubbles of Sample E in Example 5 after 5 seconds, 10 seconds, 15 seconds, 30 seconds, 35 seconds and 40 seconds are shown.

[0215] The average bubble area of ​​each sample at each time interval was determined from the digital photographs by analysis using the software of Example 3 (Cellsize, Teclis Instruments). The average bubble area of ​​each sample in Samples C, D and E was determined, and the average bubble area up to 0.04 mm was determined. 2 -0.1mm 2 Table 5 lists the time for samples C, D and E of Example 3 to reach 0.04mm 2 -0.1mm 2 Time range for average bubble area.

[0216] Table 6.

[0217]

[0218] Table 6 shows that the flavored samples (samples D and E) reached 0.04 mm 2 -0.1mm 2The time range of the average bubble area is greater than that of the unflavored sample (Sample C). Table 6 also shows that the cola flavored sample (Sample D) reaches 0.04 mm 2 -0.1mm 2 The time range of the average bubble area is greater than that of the sample with lemon-lime flavor (Sample E).

[0219] Example 7 :

[0220] Samples corresponding to low-calorie beverages were prepared using a combination of steviol glycosides, bubble modifiers and / or flavoring agents. High-purity rebaudioside M (>95% total steviol glycosides (JECFA 9+rebaudioside M), which contained approximately 87.5% rebaudioside M and approximately 10.4% rebaudioside D) was used. As described above, the bubble modifier was a plant extract derived from yerba mate (Cargill batch number YM20180628). The bubble modifier contained greater than 40% dicaffeoylquinic acid and / or its salt. Samples 1-9 had steviol glycoside concentrations, bubble modifier concentrations, orange flavoring agents and / or sodium benzoate preservatives (final concentration of 0.015%) as shown in Table 11 below. The samples were unflavored (water) or orange flavored. The samples were prepared with distilled water. The samples were unbuffered except for Sample 5 which had 0.098% anhydrous citric acid and 0.026% potassium citrate monohydrate.

[0221] Table 11.

[0222]

[0223] Samples 1-9 were prepared as described above. Protocol 1 was performed with a bubbling rate of 150 ml / min using a 40 s air bubbling time to analyze the foam properties of each of the individual samples 1-9. Several measurements were performed on each individual sample. The initial liquid volume was 60 ml. Air, nitrogen and carbon dioxide gas were each used as the bubbling gas for each of the samples 1-9. The foam capacity (FC), maximum foam density (MD), foam expansion (FE), foam capacity (FC) and volume stability (t 泡沫1 / 2 ). The final foam conductivity was also measured.

[0224] The results for Protocol 1 (air, nitrogen, and carbon dioxide gas bubbling for 40 seconds) for Samples 1 and 2 are shown in Table 12.

[0225] Table 12.

[0226]

[0227]

[0228] Table 12 shows that for Sample 1, bubbling with carbon dioxide gas reduces the final foam volume and foam capacity compared with bubbling with air or bubbling with nitrogen. Table 12 shows that for Sample 2, bubbling with carbon dioxide gas reduces the final foam volume and foam capacity compared with bubbling with air or bubbling with nitrogen.

[0229] The results of Protocol 1 (air, nitrogen, and carbon dioxide gas bubbling for 40 seconds) for Samples 3 and 4 are shown in Table 13.

[0230] Table 13.

[0231]

[0232]

[0233] Table 13 shows that for Sample 4, bubbling with carbon dioxide gas reduced the final foam volume and foam capacity compared to bubbling with air or bubbling with nitrogen gas.

[0234] The results for Protocol 1 (air, nitrogen, and carbon dioxide gas bubbling for 40 seconds) for Samples 5 and 6 are shown in Table 14.

[0235] Table 14.

[0236]

[0237]

[0238] Table 14 shows that, for Sample 5, bubbling with carbon dioxide gas reduces the final foam volume and foam capacity compared with bubbling with air or bubbling with nitrogen. Table 14 shows that, for Sample 6, bubbling with carbon dioxide gas reduces the final foam volume and foam capacity compared with bubbling with air or bubbling with nitrogen.

[0239] The results of Protocol 1 (air, nitrogen, and carbon dioxide gas bubbling for 40 seconds) for Samples 7 and 8 are shown in Table 15.

[0240] Table 15.

[0241]

[0242]

[0243] Table 15 shows that, for Sample 7, bubbling with carbon dioxide gas reduces the final foam volume and foam capacity compared with bubbling with air or bubbling with nitrogen. Table 15 shows that, for Sample 8, bubbling with carbon dioxide gas reduces the final foam volume and foam capacity compared with bubbling with air or bubbling with nitrogen.

[0244] The results for Protocol 1 (air, nitrogen, and carbon dioxide gas bubbling for 40 seconds) for Sample 9 are shown in Table 16.

[0245] Table 16.

[0246]

[0247] Table 16 shows that for Sample 9, bubbling with carbon dioxide gas reduced the final foam volume and foam capacity compared to bubbling with air or bubbling with nitrogen gas.

[0248] Example 8 :

[0249] For Example 8, the bubble characteristics were observed by digital photography. Digital photos of the foam bubbles in the corresponding samples were taken at regular intervals at the beginning of air bubbling, throughout the air bubbling process, and during the decay of the generated foam. Digital photos of samples 1, 2, 5, 6, and 7, which were bubbled with air and bubbled with nitrogen, were recorded. Digital photos were recorded at 0s, 15s, 40s, 65s, and 90s. Figure 5A Digital photographs of bubbles of Sample 1 (water (Reb M)) sparged with air and sparged with nitrogen at 0 s, 15 s, 40 s, 65 s and 90 s are shown. Figure 5B Digital photographs of bubbles of Sample 5 (water (Reb M, bubble modifier)) sparged with air and sparged with nitrogen at 0 s, 15 s, 40 s, 65 s, and 90 s are shown. Figure 5C Digital photographs of bubbles of Sample 7 (water (Reb M, bubble modifier, preservative)) sparged with air and sparged with nitrogen at 0 s, 15 s, 40 s, 65 s, and 90 s are shown. Fig. 6A Digital photographs of the bubbles of Sample 2 (orange flavor (Reb M)) are shown, bubbling with air and bubbling with nitrogen at 0 s, 15 s, 40 s, 65 s and 90 s. Figure 6B Digital photographs of bubbles of Sample 6 (orange flavor (Reb M, bubble modifier)) are shown, wherein sparging with air and sparging with nitrogen at 0 s, 15 s, 40 s, 65 s, and 90 s.

[0250] Fig. 7A is a graph plotting the calculated average bubble area of ​​the bubbles in the photographs of Figures 5-6 over a 100 second time span for the sample bubbled with air. Figure 7B is a graph plotting the calculated average bubble area of ​​the bubbles in the photographs of Figures 5-6 over a 100 second time span for the sample bubbled with nitrogen. Figure 7C is a graph plotting the calculated average bubble area of ​​the bubbles in the photographs of Figures 5-6 over a 100 second time span for samples bubbled with air and nitrogen. Figure 7C is a graph plotting the calculated average bubble area over a 100 second time span for the orange flavored water samples bubbled with air and nitrogen in the photographs of FIGS. 5-6 .

[0251] Example 9 :

[0252] Beverage model systems (carbonated water) were prepared with and without a bubble enhancer. Samples were prepared by dosing a small amount of concentrated SE solution (1% in distilled water) into a 1 oz plastic portion cup and filling with carbonated water to obtain a final concentration of 0 to 600 ppm (in 100 ppm increments). The following comments were from four individuals familiar with sensory evaluation of beverages.

[0253] Carbonated water (0-600ppm) :

[0254] Vision

[0255] a. For the system containing the bubble modifier, the number of bubbles sticking to the sides of the plastic cup increased.

[0256] b. For the system containing the bubble modifier, the number of bubbles sticking to the sides of the plastic cup is reduced.

[0257] c. For the system containing the bubble modifier, the bubbles appear to condense more slowly as the concentration of the bubble modifier increases.

[0258] d. For the system containing bubble modifier, smaller bubbles exist on the wall of the plastic cup for a longer time.

[0259] e. When the bubble modifier is 400 ppm or less, the solution has no obvious color.

[0260] smell

[0261] a. Compared with the system without any bubble modifier, the "fineness" of the bubble mouthfeel in the system containing the bubble modifier is significantly increased.

[0262] b. It was noted that at 300 ppm of the bubble modifier, the sour taste perception was slightly enhanced.

[0263] c. A slight astringent taste was felt when the bubble modifier was 500 ppm.

[0264] d. A slight astringent taste was felt when the bubble modifier was 600 ppm.

[0265] e. A slight "brown fruit" taste was noted at 600 ppm of the bubble modifier.

[0266] No other vegetal flavors were detected at any of the above concentrations.

[0267] Figure 8 are photographs showing, from left to right, samples with 0 ppm, 100 ppm, and 400 ppm of bubble modifier.

Claims

1. A gasified aqueous solution having a reduced average bubble diameter, the gasified aqueous solution comprising: a. a content of dissolved gas, said content of said dissolved gas will cause said gasified aqueous solution to effervesce at an ambient air pressure of 15.6°C and 1 atmosphere (STP), and b. a bubble modifier, the bubble modifier comprising one or more compounds selected from the group consisting of dicaffeoylquinic acid and salts thereof, the one or more compounds being present in the gasified aqueous solution at a total concentration of 50 ppm to 1600 ppm, the total concentration of the one or more compounds being effective to reduce the average bubble diameter within the matrix of the aqueous solution at STP within 1 minute after the onset of effervescence, compared to the gasified aqueous solution not containing the bubble modifier; wherein the dicaffeoylquinic acid comprises at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid; and wherein the bubble modifier comprises less than 0.3 wt % of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid. Fruit acid; or less than 0.05 weight % of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate or acetic acid; or less than 0.05 weight % of chlorophyll; or less than 0.1 weight % of furan, furan-containing chemicals, theobromine, theophylline or trigonelline, the weight percentages being based on the dry weight of the bubble modifier, wherein the gasified aqueous solution comprises a steviol glycoside compound, and the steviol glycoside compound comprises rebaudioside M.

2. The gasified aqueous solution according to claim 1, wherein the gasified aqueous solution comprises at least 80 wt% of rebaudioside M based on the total weight of steviol glycoside compounds in the gasified aqueous solution.

3. The gasified aqueous solution according to any one of the preceding claims, wherein the gasified aqueous solution comprises rebaudioside M and rebaudioside D. 4 . The gasified aqueous solution according to claim 1 , wherein the concentration of the bubble modifier is 50 ppm to 600 ppm. 5 . The gasified aqueous solution according to claim 1 , wherein the concentration of the bubble modifier is 100 ppm to 500 ppm.

6. The gasified aqueous solution of claim 1, wherein the bubble modifier comprises a dicaffeoylquinic acid component, wherein the dicaffeoylquinic acid component comprises at least one compound selected from the group consisting of 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof.

7. The gasified aqueous solution according to claim 1, wherein the total amount of all dicaffeoylquinic acid and dicaffeoylquinic acid salts present in the gas bubble modifier accounts for 10 wt% or more of the total weight of the gas bubble modifier.

8. The gasified aqueous solution of claim 1, wherein the total amount of all dicaffeoylquinic acid and dicaffeoylquinic acid salts present in the gas bubble modifier accounts for 25 wt% to 75 wt% of the total weight of the gas bubble modifier.

9. The gasified aqueous solution according to claim 1, wherein the total amount of all dicaffeoylquinic acid and dicaffeoylquinic acid salts present in the gas bubble modifier accounts for 40 wt% to 60 wt% of the total weight of the gas bubble modifier.

10. The gasified aqueous solution according to claim 1, wherein the bubble modifier comprises a dicaffeoylquinic acid component and a monocaffeoylquinic acid component, the dicaffeoylquinic acid component comprising at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof, and the monocaffeoylquinic acid component comprising at least one compound selected from the group consisting of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid and salts thereof.

11. The gasified aqueous solution according to claim 1, wherein the bubble modifier comprises a dicaffeoylquinic acid component and a monocaffeoylquinic acid component, the dicaffeoylquinic acid component comprising at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof, the monocaffeoylquinic acid component comprising at least one compound selected from the group consisting of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid and salts thereof; and wherein the monocaffeoylquinic acid component and the dicaffeoylquinic acid component together account for more than 50% by weight of the bubble modifier.

12. The gasified aqueous solution of claim 1, wherein the solution is gasified with a content of the gas at least 50% higher than the equilibrium saturation value of the gas at STP.

13. The gasified aqueous solution of claim 1, wherein the gas bubble modifier comprises 0 wt% malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate, or malic acid; or 0 wt% chlorophyll.

14. A beverage product comprising the gasified water solution according to any one of claims 1 to 13.

15. A non-alcoholic beverage product comprising the gasified aqueous solution according to any one of claims 1 to 13.

16. A modified steviol glycoside solution, wherein the modified steviol glycoside solution forms a foam having a reduced average bubble diameter, the modified steviol glycoside solution comprising: a. steviol glycosides at a concentration of at least 20 ppm; and b. a bubble modifier, the bubble modifier comprising one or more compounds selected from the group consisting of dicaffeoylquinic acid and salts thereof, the one or more compounds being present in the modified steviol glycoside solution at a concentration of 50 ppm to 1600 ppm, the concentration of the one or more compounds effectively reducing the average bubble diameter in the foam compared to an aqueous solution not containing the bubble modifier; wherein the average bubble diameter is measured by a Foamscan test, delivering gas to 60 ml of the modified steviol glycoside solution at a temperature of 15.6° C. at an airflow rate of 150 ml / min for 60 seconds, and measuring the average bubble diameter of bubbles in the foam at a pressure of 1 atmosphere 30 seconds after the completion of the gas delivery; wherein the ratio of the total concentration of the one or more compounds in the modified steviol glycoside solution to the total concentration of the steviol glycosides is between 0.1 and 10; and wherein the gas bubble modifier comprises less than 0.3 wt % of malonate, malonic acid, oxalate, oxalic acid, lactate, lactic acid, succinate, succinic acid, malate or malic acid; or less than 0.05 wt % of pyruvate, pyruvic acid, fumarate, fumaric acid, tartrate, tartaric acid, sorbate, sorbic acid, acetate or acetic acid; or less than 0.05 wt % of chlorophyll; or less than 0.1 wt % of furan, furan-containing chemical, theobromine, theophylline or trigonelline, the weight percentages being based on the dry weight of the gas bubble modifier, wherein the steviol glycoside comprises rebaudioside M, and The dicaffeoylquinic acid includes at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid.

17. The modified steviol glycoside solution according to claim 16, wherein the bubble modifier comprises a dicaffeoylquinic acid component, wherein the dicaffeoylquinic acid component comprises at least one compound selected from the group consisting of 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof.

18. The modified steviol glycoside solution according to claim 16 or claim 17, wherein the concentration of the bubble modifier is 50 ppm to 600 ppm.

19. The modified steviol glycoside solution according to claim 16 or claim 17, wherein the concentration of the bubble modifier is 100 ppm to 500 ppm.

20. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the total amount of all dicaffeoylquinic acid and dicaffeoylquinic acid salts present in the gas bubble modifier accounts for 10 wt% or more of the total weight of the gas bubble modifier.

21. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the total amount of all dicaffeoylquinic acid and dicaffeoylquinic acid salts present in the gas bubble modifier accounts for 25 wt% to 75 wt% of the total weight of the gas bubble modifier.

22. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the total amount of all dicaffeoylquinic acid and dicaffeoylquinic acid salts present in the gas bubble modifier accounts for 40 wt% to 60 wt% of the total weight of the gas bubble modifier.

23. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the bubble modifier comprises a dicaffeoylquinic acid component and a monocaffeoylquinic acid component, the dicaffeoylquinic acid component comprising at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof, and the monocaffeoylquinic acid component comprising at least one compound selected from the group consisting of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid and salts thereof.

24. The modified steviol glycoside solution according to claim 16, wherein the gas bubble modifier comprises a dicaffeoylquinic acid component and a monocaffeoylquinic acid component, the dicaffeoylquinic acid component comprising at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof, and the monocaffeoylquinic acid component comprising at least one compound selected from the group consisting of chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid and salts thereof; and wherein the monocaffeoylquinic acid component and the dicaffeoylquinic acid component together account for more than 50% by weight of the gas bubble modifier.

25. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the steviol glycoside further comprises at least one of rebaudioside A, rebaudioside B, and rebaudioside D.

26. The modified steviol glycoside solution of any one of claims 16 to 17, wherein the steviol glycoside comprises at least 80 wt% rebaudioside M based on the total weight of steviol glycoside compounds in the sweetening composition.

27. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the steviol glycoside comprises rebaudioside M and rebaudioside D.

28. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the steviol glycoside concentration is 100 ppm to 1600 ppm.

29. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the steviol glycoside concentration is 10 ppm to 25 ppm.

30. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the steviol glycoside concentration is 100 ppm to 1600 ppm, and the bubble modifier concentration is 50 ppm to 400 ppm.

31. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the concentration of the bubble modifier is 100 ppm to 300 ppm.

32. The modified steviol glycoside solution of any one of claims 16 to 17, wherein the sweetening composition has a pH of 2 to 4.

33. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein the gas bubble modifier is prepared from a plant source.

34. The modified steviol glycoside solution according to any one of claims 16 to 17, wherein at least a portion of the gas bubble modifier is prepared from yerba mate, chicory, rosemary, artichoke, cardoon, or stevia.

35. The modified steviol glycoside solution of claim 16, wherein the steviol glycoside concentration is 20 ppm to 24 ppm.

36. A beverage product comprising the modified steviol glycoside solution according to any one of claims 16 to 35, wherein the beverage is gasified with one or more gases selected from the group consisting of air, nitrogen and carbon dioxide.

37. A foam having an increased foam capacity or FC 30 The modified steviol glycoside solution comprises: a. steviol glycosides at a concentration of at least 10 ppm; and b. Bubble modifier at a concentration of 50ppm to 1600ppm, The bubble modifier and the steviol glycoside are each effective to provide the modified steviol glycoside solution with a foam capacity or FC of at least 0.

8. 30 The concentration exists, where FC 30 The foam capacity is determined as the foam volume divided by the volume of air delivered to the modified steviol glycoside solution in the Foamscan test, wherein the steviol glycoside comprises rebaudioside M, The bubble modifier comprises one or more compounds selected from the following: dicaffeoylquinic acid and their salts, The dicaffeoylquinic acid includes at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid.

38. The modified steviol glycoside solution of claim 37, wherein the bubble modifier and the steviol glycoside are each effective to provide a foam capacity or FC of at least 0.

9. 30 The amount exists.

39. The modified steviol glycoside solution of claim 37, wherein the bubble modifier and the steviol glycoside are each effective to provide a foam capacity or FC of at least 1.

0. 30 The amount exists.

40. The modified steviol glycoside solution according to claim 37, wherein the air bubble modifier comprises 10 wt% or more of a compound selected from dicaffeoylquinic acid and a salt thereof, based on the total weight of the air bubble modifier.

41. The modified steviol glycoside solution according to claim 37, wherein the air bubble modifier comprises 15 wt% or more of a compound selected from dicaffeoylquinic acid and a salt thereof, based on the total weight of the air bubble modifier.

42. The modified steviol glycoside solution of claim 37, wherein the bubble modifier further comprises monocaffeoylquinic acid, wherein the monocaffeoylquinic acid comprises one or more compounds selected from the group consisting of 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, and 5-O-caffeoylquinic acid.

43. The modified steviol glycoside solution of claim 37, wherein the bubble modifier comprises dicaffeoylquinic acid, wherein the dicaffeoylquinic acid comprises one or more compounds selected from the group consisting of 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof.

44. The modified steviol glycoside solution according to any one of claims 37 to 43, wherein the steviol glycoside further comprises at least one of rebaudioside A, rebaudioside B, and rebaudioside D.

45. The modified steviol glycoside solution of any one of claims 37 to 43, wherein the steviol glycosides comprise at least 80 wt% rebaudioside M by weight, based on the total weight of steviol glycosides in the sweetening composition.

46. ​​The modified steviol glycoside solution of any one of claims 37 to 43, wherein the steviol glycosides comprise rebaudioside M and rebaudioside D.

47. The modified steviol glycoside solution of any one of claims 37 to 43, wherein the sweetening composition has a steviol glycoside concentration of 100 ppm to 1600 ppm.

48. The modified steviol glycoside solution of any one of claims 37 to 43, wherein the sweetening composition has a steviol glycoside concentration of 100 ppm to 1600 ppm and a bubble modifier concentration of 100 ppm to 1600 ppm.

49. The modified steviol glycoside solution of any one of claims 37 to 43, wherein the ratio of steviol glycoside to gas-gas modifier in the sweetening composition is between 1.17 and 2.

5.

50. The modified steviol glycoside solution of any one of claims 37 to 43, wherein the sweetening composition has a pH of 2 to 4.

51. The modified steviol glycoside solution of any one of claims 37 to 43, wherein the gas bubble modifier is prepared from a plant source.

52. The modified steviol glycoside solution of any one of claims 37 to 43, wherein at least a portion of the gas bubble modifier is prepared from yerba mate, chicory, rosemary, artichoke, cardoon, or stevia.

53. A beverage comprising the modified steviol glycoside solution according to any one of claims 37 to 52, wherein the beverage is gasified with one or more gases selected from the group consisting of air, nitrogen and carbon dioxide.

54. A method for reducing the size of bubbles formed by the gasified aqueous solution of any one of claims 1 to 13, the method comprising adding a bubble modifier to the aqueous solution after the aqueous solution is gasified, before the aqueous solution is gasified, or while the aqueous solution is gasified.

55. A method for increasing the volume, volume stability, foam capacity, foam expansion and / or foam density of foam produced by the gasified aqueous solution of any one of claims 1 to 13, the method comprising adding a bubble modifier and steviol glycoside to the aqueous solution after the aqueous solution is gasified, before the aqueous solution is gasified, or while the aqueous solution is gasified.

56. A foam having an increased foam capacity or FC 30 The modified steviol glycoside solution comprises: a. steviol glycosides at a concentration of at least 10 ppm; and b. a bubble modifier, the bubble modifier comprising one or more compounds selected from the group consisting of dicaffeoylquinic acid and salts thereof, wherein the one or more compounds are present in the modified steviol glycoside solution at a concentration of 50 ppm to 1600 ppm, wherein the ratio of the total concentration of the one or more compounds in the modified steviol glycoside solution to the total concentration of the steviol glycosides is between 0.1 and 10; and The bubble modifier and the steviol glycoside are each effective to provide the modified steviol glycoside solution with a foam capacity or FC of at least 0.

8. 30 The concentration exists, where FC 30 The foam capacity is determined as the foam volume divided by the volume of air delivered to the modified steviol glycoside solution in the Foamscan test, wherein the steviol glycoside comprises rebaudioside M, The dicaffeoylquinic acid includes at least one compound selected from the group consisting of 1,3-dicaffeoylquinic acid, 1,4-dicaffeoylquinic acid, 1,5-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid.

57. The modified steviol glycoside solution of claim 56, wherein the steviol glycoside further comprises at least one of rebaudioside A, rebaudioside B, and rebaudioside D.

58. The modified steviol glycoside solution of claim 56, wherein the steviol glycoside comprises at least 80 wt% rebaudioside M by weight based on the total weight of steviol glycosides in the modified steviol glycoside solution.

59. The modified steviol glycoside solution of claim 56, wherein the steviol glycosides comprise rebaudioside M and rebaudioside D.

60. The modified steviol glycoside solution of claim 56, wherein the modified steviol glycoside solution has a steviol glycoside concentration of 100 ppm to 1600 ppm.

61. The modified steviol glycoside solution of claim 56, wherein the modified steviol glycoside solution has a steviol glycoside concentration of 100 ppm to 1600 ppm and a bubble modifier concentration of 100 ppm to 1600 ppm.

62. The modified steviol glycoside solution of claim 56, wherein the ratio of the steviol glycoside to the gas bubble modifier in the modified steviol glycoside solution is between 1.17 and 2.

5.

63. The modified steviol glycoside solution of claim 56, wherein the modified steviol glycoside solution has a pH of 2 to 4.

64. The modified steviol glycoside solution of claim 56, wherein the bubble modifier and the steviol glycoside are each effective to provide a foam capacity or FC of at least 0.

9. 30 The amount exists.

65. The modified steviol glycoside solution of claim 56, wherein the bubble modifier and the steviol glycoside are each effective to provide a foam capacity or FC of at least 1.

0. 30 The amount exists.

66. The modified steviol glycoside solution according to claim 56, wherein the air bubble modifier comprises 10 wt% or more of a compound selected from dicaffeoylquinic acid and a salt thereof, based on the total weight of the air bubble modifier.

67. The modified steviol glycoside solution according to claim 56, wherein the air bubble modifier comprises 15 wt% or more of a compound selected from dicaffeoylquinic acid and a salt thereof, based on the total weight of the air bubble modifier.

68. The modified steviol glycoside solution of claim 56, wherein the bubble modifier further comprises monocaffeoylquinic acid, wherein the monocaffeoylquinic acid comprises one or more compounds selected from the group consisting of 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, and 5-O-caffeoylquinic acid.

69. The modified steviol glycoside solution of claim 56, wherein the dicaffeoylquinic acid comprises one or more compounds selected from the group consisting of 3,4-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid and salts thereof.

70. A beverage comprising the modified steviol glycoside solution according to any one of claims 56 to 69, wherein the beverage is gasified with one or more gases selected from the group consisting of air, nitrogen and carbon dioxide.

Citation Information

Patent Citations

  • Contextually prompting users to switch communication modes

    US20180054691A1

  • Resource Processing Method and Device

    US20180054804A1

  • Steviol glycoside compositions with reduced surface tension

    US20190223482A1

  • Preparation of noncarbonated beverage products with improved microbial stability

    CN1144459A

  • Composition containing dicaffeoyl quinic acid and its preparing method

    CN1615838A